الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease. | Dilaforette AB | Ongoing | Sevuparin | 2 | TVOC01 | King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Qatif Central Hospital |
| Multicenter Inetrnational neoadjuvant randomized double-blind trial comparing fulvestrant to a combination of fulvestrant and palcociclib in patients with operable luminal breast cancer responding to fulvestrant | ICR Group - International Cancer Research group | Ongoing | palbociclib fulvestrant | 3 | ICRG 1201 | King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age | Shire Human Genetic Therapies, Inc | Ongoing | Elaprase | 4 | SHPELA401 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A MULTICENTER, PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF USING TOCILIZUMAB (TCZ) FOR CONFIRMED RHEUMATOID ARTHRITIS (RA) PATIENTS IN CLINICAL PRACTICE | Roche | Ongoing | tocilizumab | 4 | ML299336 | King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh) |
| "CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group studycomparing pre-discharge and posT-discharge tReatmentinitiation with LCZ696 in heArt failure patieNtS withreduced ejectIon-fracTion hospItalized for an acutedecOmpensation eveNt (ADHF)" | Novartis | Ongoing | Entresto (SACUBITRIL, VALSARTAN) | 4 | CZ696B2401 | Saud Al-Babtain Cardiac Center (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Khalid University Hospital (Riyadh) |
| "A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition tothe Paliperidone Palmitate 3-Month Formulation in Patients with SchizophreniaPreviously Stabilized on the Paliperidone Palmitate 1-Month Formulation" | Janssen-Cilag International NV | Ongoing | paliperidone | 3 | R092670SCH3015 | Jeddah psychiatric hospital, Al-Amal Complex for mental health (Dammam) |
| "A Randomized controlled Trial of Influenza Vaccineto Reduce Adverse Vascular Events" | McMaster University | Ongoing | Vaxigrip | 3 | version 2 | King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah), King Fahad Medical City (Riyadh), Madinah Cardiac Center |
| "Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial withan open-label extension that investigates the effect of the addition of dulaglutide (0.75 and1.5 mg/week) or placebo weekly to metformin and/or basal insulin on change from baselinein hemoglobin A1c at 26 weeks in children and adolescents with type 2 diabetes mellitus" | Eli Lilly | Ongoing | Dulaglutide 0.75 /1.5 mg | 3 | H9X-MC-GBGC | King Khalid University Hospital (Riyadh), International Medical Center (Jeddah) |
| RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity | Novartis | Ongoing | Ranibizumab | 3 | CRFB002H2301 V 01 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity | Novartis | Ongoing | Ranibizumab | 3 | CRFB002H2301 V 01 | King Faisal Specialist Hospital and Research Center (Riyadh) |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.